Site icon OncologyTube

Second Line Bladder Cancer and PD-L1 – Nicholas J. Vogelzang, MD

Nicholas J. Vogelzang, MD of the University of Illinois discusses second line bladder cancer and PD-L1 antibody

Exit mobile version